Features | Partner Sites | Information | LinkXpress
Sign In
BioConferenceLive
GLOBETECH PUBLISHING
JIB

Methodic Strategy Developed for 3D Tissue Engineering of Viable Organ Implants

By BiotechDaily International staff writers
Posted on 27 Aug 2013
Image: Confocal microscopy images showing the different levels of organization (Photo courtesy of Agency for Science, Technology and Research (A*STAR), Singapore).
Image: Confocal microscopy images showing the different levels of organization (Photo courtesy of Agency for Science, Technology and Research (A*STAR), Singapore).
Researchers in Singapore have developed a simple way to organize cells and their microenvironments in hydrogel fibers. Their novel technology provides a practical template for constructing complicated structures, such as liver and fat tissues.

The investigators published their findings August 19, 2013, in the journal Nature Communications. According to the Institute of Bioengineering and Nanotechnology (IBN; Singapore) executive director Prof. Jackie Y. Ying, “Our tissue engineering approach gives researchers great control and flexibility over the arrangement of individual cell types, making it possible to engineer prevascularized tissue constructs easily. This innovation brings us a step closer toward developing viable tissue or organ replacements.”

IBN team leader and lead research scientist, Dr. Andrew Wan, elaborated, “Critical to the success of an implant is its ability to rapidly integrate with the patient’s circulatory system. This is essential for the survival of cells within the implant, as it would ensure timely access to oxygen and essential nutrients, as well as the removal of metabolic waste products. Integration would also facilitate signaling between the cells and blood vessels, which is important for tissue development.”

Tissues designed with preformed vascular networks are known to foster rapid vascular integration with the host. Generally, prevascularization has been achieved by seeding or encapsulating endothelial cells, which line the interior surfaces of blood vessels, with other cell types. In many of these approaches, the eventual distribution of vessels within a thick structure is based on in vitro cellular infiltration and self-organization of the cell mixture. These are slow processes, frequently leading to a nonuniform network of vessels within the tissue. As vascular self-assembly requires a large concentration of endothelial cells, this technique also greatly restricts the number of other cells that may be co-cultured.

Alternatively, scientists have attempted to direct the distribution of newly formed vessels via three-dimensional (3D) co-patterning of endothelial cells with other cell types in a hydrogel. This approach allows large concentrations of endothelial cells to be placed in specific areas within the tissue, leaving the rest of the construct available for other cell types. The hydrogel also acts as a reservoir of nutrients for the encapsulated cells. However, co-patterning multiple cell types within a hydrogel is not easy. Traditional techniques, such as micromolding and organ printing, are limited by large volumes of cell suspension, slow cell assembly, complicated multistep processes, and costly instruments. These factors also make it difficult to scale up the production of implantable 3D cell-patterned constructs. Up to now, these strategies have not been able to achieve vascularization and mass transport through dense engineered tissues.

To overcome these hurdles, IBN researchers have used interfacial polyelectrolyte complexation (IPC) fiber assembly, a unique cell patterning technology patented by IBN, to generate cell-laden hydrogel fibers under aqueous conditions at room temperature. In contrast to other technology, IBN’s unique technique allows researchers to incorporate different cell types separately into different fibers, and these cell-laden fibers may then be assembled into more complex constructs with hierarchical tissue structures. Furthermore, IBN researchers are able to customize the microenvironment for each cell type for enhanced functionality by integrating the appropriate factors, e.g., proteins, into the fibers. Using IPC fiber assembly, the researchers have engineered an endothelial vessel network, as well as liver tissue constructs and cell-patterned fat, which have successfully integrated with the host circulatory system in a mouse model and produced vascularized tissues.

The IBN researchers are now working on applying and further developing their technology toward engineering functional tissues and clinical applications.

Related Links:
Institute of Bioengineering and Nanotechnology



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: In the liver tissue of obese animals with type II diabetes, unhealthy, fat-filled cells are prolific (small white cells, panel A). After chronic treatment through FGF1 injections, the liver cells successfully lose fat and absorb sugar from the bloodstream (small purple cells, panel B) and more closely resemble cells of normal, non-diabetic animals (Photo courtesy of the Salk Institute for Biological Studies).

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 (FGF1) removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Business

view channel

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 (corresponding to 23.8% annual growth) in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research. This notable growth... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.